Stay updated on MBG453 Combo with Azacitidine & Venetoclax Clinical Trial

Sign up to get notified when there's something new on the MBG453 Combo with Azacitidine & Venetoclax Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MBG453 Combo with Azacitidine & Venetoclax Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A site-wide notice about potential delays due to a lapse in government funding and NIH Clinical Center status was added, and the page revision updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T06:37:15.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Glossary toggle added and color-coded change highlights (green for additions, red for deletions) with a new revision label (v3.4.0). Older No FEAR Act data entry and revision v3.3.4 were removed.
    Difference
    0.5%
    Check dated 2026-01-28T04:41:04.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Latest revision v3.3.4 (2026-01-13) adds Adverse Events, Participant Flow, References, Contacts/Locations, and Study Status to the record, while the previous revision v3.3.3 was removed.
    Difference
    0.5%
    Check dated 2026-01-14T02:17:12.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The history page adds a new entry 'Revision: v3.3.3' and removes the footer items 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'.
    Difference
    0.1%
    Check dated 2025-12-23T21:21:06.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    Revision from v3.2.0 to v3.3.2 is reflected on the page; no study data or page content is affected.
    Difference
    0.1%
    Check dated 2025-11-25T11:32:13.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Novartis decided to early terminate the sabatolimab clinical development program, including the CMBG453C12201 trial, following negative results from two other trials. The history also removes a government-funding notice and records that the study was terminated due to negative results across the program.
    Difference
    0.8%
    Check dated 2025-11-18T07:13:15.000Z thumbnail image

Stay in the know with updates to MBG453 Combo with Azacitidine & Venetoclax Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MBG453 Combo with Azacitidine & Venetoclax Clinical Trial page.